{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:32:36Z","timestamp":1776511956077,"version":"3.51.2"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Summer Student Award from the Division of Geriatric Medicine, University of Alberta","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Aim<\/jats:title>\n<jats:p>Mild cognitive impairment (MCI) is the prodromal phase of dementia. The objective of this study was to determine whether specific antihypertensives were associated with conversion from MCI to dementia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this retrospective study, a chart review was conducted on 335 older adults seen at the University of Alberta Hospital, Kaye Edmonton Seniors Clinic who were diagnosed with MCI. At the point of diagnosis, data was collected on demographic and lifestyle characteristics, measures of cognitive function, blood pressure measurements, use of antihypertensives, and other known or suspected risk factors for cognitive decline. Patients were followed for 5.5 years for dementia diagnoses. A logistic regression analysis was then conducted to determine the factors associated with conversion from MCI to dementia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Mean age (\u00b1 standard deviation) of the study participants was 76.5 \u00b1 7.3 years. Patients who converted from MCI to dementia were significantly older and were more likely to have a family history of dementia. After controlling for potential confounders including age, sex, Mini Mental Status Exam scores and family history of dementia, patients who were on beta-blockers (BBs) had a 57% reduction in the odds of converting to dementia (OR: 0.43, 95% CI: 0.23, 0.81).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this study, BB use was protective against conversion from MCI to dementia. Further studies are required to confirm the findings of our study and to elucidate the effect of BBs on cognitive decline.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0295658","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T18:26:20Z","timestamp":1703096780000},"page":"e0295658","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between use of antihypertensives and cognitive decline in the elderly\u2014A retrospective observational study"],"prefix":"10.1371","volume":"18","author":[{"given":"Prabhpaul","family":"Dhami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1444-2451","authenticated-orcid":true,"given":"Kannayiram","family":"Alagiakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-1376","authenticated-orcid":true,"given":"Ambikaipakan","family":"Senthilselvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"issue":"1","key":"pone.0295658.ref001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"M Prince","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"3","key":"pone.0295658.ref002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"MS Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1","key":"pone.0295658.ref003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452486","article-title":"The risk of incident mild cognitive impairment and progression to dementia considering mild cognitive impairment subtypes","volume":"7","author":"TL Michaud","year":"2017","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"1","key":"pone.0295658.ref004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.110.163055","article-title":"Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study","volume":"58","author":"T Ninomiya","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"pone.0295658.ref005","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the American Heart Association","volume":"68","author":"C Iadecola","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"pone.0295658.ref006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11906-017-0724-3","article-title":"Defining the relationship between hypertension, cognitive decline, and dementia: a Review","volume":"19","author":"KA Walker","year":"2017","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"pone.0295658.ref007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/08037051.2018.1507621","article-title":"Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study","volume":"27","author":"SE Kjeldsen","year":"2018","journal-title":"Blood Press"},{"issue":"8","key":"pone.0295658.ref008","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data","volume":"13","author":"S Norton","year":"2014","journal-title":"Lancet Neurol"},{"issue":"6","key":"pone.0295658.ref009","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis","volume":"31","author":"NL Marpillat","year":"2013","journal-title":"J Hypertens"},{"key":"pone.0295658.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2017.07.015","article-title":"Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review","volume":"46","author":"M Stuhec","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"1","key":"pone.0295658.ref011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.121.17283","article-title":"Blood pressure levels and risks of dementia: a nationwide study of 4.5 million people","volume":"79","author":"CJ Lee","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"pone.0295658.ref012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5414\/CP201284","article-title":"Antihypertensive treatment and risk of dementia: a retrospective database study","volume":"50","author":"G Wagner","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"key":"pone.0295658.ref013","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijcard.2016.11.193","article-title":"Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European Consortium Criteria","volume":"228","author":"K Alagiakrishnan","year":"2017","journal-title":"Int J Cardiol"},{"issue":"3","key":"pone.0295658.ref014","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1474515111435606","article-title":"Screening for mild cognitive impairment in patients with heart failure: Montreal Cognitive Assessment versus Mini Mental State Exam","volume":"12","author":"J Cameron","year":"2013","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"12","key":"pone.0295658.ref015","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"RC Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"pone.0295658.ref016","first-page":"143","volume-title":"Diagnosis and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","edition":"4"},{"key":"pone.0295658.ref017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fcvm.2020.00005","article-title":"Hypertension and the risk of dementia","volume":"7","author":"C Sierra","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"pone.0295658.ref018","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"L Rouch","year":"2015","journal-title":"CNS Drugs"},{"issue":"9","key":"pone.0295658.ref019","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jgs.13627","article-title":"Modulation of renin-angiotensin system may slow conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"63","author":"W Wharton","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"32","key":"pone.0295658.ref020","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1523\/JNEUROSCI.1549-07.2007","article-title":"Angiotensin-converting enzyme converts amyloid \u03b2-protein 1\u201342 (A\u03b21\u201342) to A\u03b21\u201340, and its inhibition enhances brain A\u03b2 deposition","volume":"27","author":"K Zou","year":"2007","journal-title":"J Neurosci"},{"issue":"12","key":"pone.0295658.ref021","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series","volume":"69","author":"I Hajjar","year":"2012","journal-title":"Archives of Neurology"},{"issue":"3","key":"pone.0295658.ref022","first-page":"541","article-title":"Risk of Developing Alzheimer\u2019s Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up","volume":"12","author":"XL Du","year":"2022","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"7 supplement","key":"pone.0295658.ref023","article-title":"Beta Blocker Treatment of Hypertensive Older Persons Ameliorates the Brain Lesions of Dementia Measured at Autopsy: The Honolulu-Asia Aging Study (S44. 005)","volume":"80","author":"W Lon","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"pone.0295658.ref024","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/EDE.0000000000001245","article-title":"Comparison of Antihypertensive Drug Classes for Dementia Prevention","volume":"31","author":"VM Walker","year":"2020","journal-title":"Epidemiology"},{"issue":"10","key":"pone.0295658.ref025","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1017\/S1461145713000631","article-title":"Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer\u2019s transgenic mice","volume":"16","author":"M Dobarro","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"pone.0295658.ref026","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4103\/1673-5374.193241","article-title":"Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer\u2032s disease mice","volume":"11","author":"GS Chai","year":"2016","journal-title":"Neural Regen Res"},{"key":"pone.0295658.ref027","doi-asserted-by":"crossref","first-page":"105089","DOI":"10.1016\/j.nbd.2020.105089","article-title":"Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer\u2019s Disease","volume":"146","author":"AK Evans","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"3","key":"pone.0295658.ref028","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/brain\/awac076","article-title":"Blood\u2013brain barrier permeable \u03b2-blockers linked to lower risk of Alzheimer\u2019s disease in hypertension","volume":"146","author":"EE Beaman","year":"2023","journal-title":"Brain"},{"issue":"12","key":"pone.0295658.ref029","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1485","article-title":"Activation of \u03b22-adrenergic receptor stimulates \u03b3-secretase activity and accelerates amyloid plaque formation","volume":"12","author":"Y Ni","year":"2006","journal-title":"Nature Medicine"},{"issue":"2","key":"pone.0295658.ref030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2010.11.004","article-title":"Roles of \u03b2-adrenergic receptors in Alzheimer\u2019s disease: Implications for novel therapeutics","volume":"84","author":"JT Yu","year":"2011","journal-title":"Brain Research Bulletin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0295658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T18:26:37Z","timestamp":1703096797000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0295658"}},"subtitle":[],"editor":[{"given":"Masaki","family":"Mogi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0295658","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]}}}